Resolution: standard / high

Figure 2.

Antitumor activity against murine melanoma B16-F10 in C57BL/6 mice following administration of TGIK in comparison to incomplete formulations.

Hill et al. Journal of Immune Based Therapies and Vaccines 2005 3:5 doi:10.1186/1476-8518-3-5
Download authors' original image